Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA¹ Exceed Guidance.
Los Angeles, CA – Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, reported financial results for the fourth quarter and year ended December 31, 2025.
“We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo’s investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions.”
– Stephan Gratziani, CEO
Highlights
Fourth Quarter 2025
Net sales up 6.3% vs. Q4 ‘24 to $1.3 billion; exceeds guidance
Up 5.5% year-over-year on constant currency basis2; exceeds guidance
Net income attributable to Herbalife of $85.4 million; adjusted net income1 of $47.5 million
Adjusted EBITDA1 of $156.1 million, or $167.7 million on a constant currency basis2; both exceed guidance
Diluted EPS of $0.81; adjusted diluted EPS1 of $0.45
Full-Year 2025
Net sales up 0.9% vs. 2024 to $5.0 billion; exceeds guidance
Includes 160 basis points of foreign currency (“FX”) headwind
Up 2.5% year-over-year on constant currency basis2, exceeds guidance
Net income attributable to Herbalife of $228.3 million; adjusted net income1 of $219.4 million
Adjusted EBITDA1 of $657.6 million, or $713.9 million on a constant currency basis2; both exceed guidance
Credit Agreement EBITDA1 of